Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Therapeutic Application
6.1 Arthritis
6.2 Cancer
6.3 Asthma & Airway Inflammation
Chapter 7 Market Segmentation by Cytokine Type
7.1 Epidermal Growth Factor-EGF
7.2 Interleukins-II
7.3 Interferons-IFN
7.4 Tumour Necrosis Factor-TNF
7.5 Others
Chapter 8 Market Segmentation by Geography
8.1 Asia Pacific
8.1.1 Introduction
8.1.2 China
8.1.3 India
8.1.4 Japan
8.1.5 Australia & New Zealand
8.1.6 Others
8.2 North America
8.2.1 Introduction
8.2.2 United States
8.2.3 Canada
8.2.4 Mexico
8.2.5 Others
8.3 Europe
8.3.1 Introduction
8.3.2 Spain
8.3.3 UK
8.3.4 France
8.3.5 Russia
8.3.6 Italy
8.3.7 Others
8.4 The Middle East and Africa
8.4.1 Introduction
8.4.2 South Africa
8.4.3 Middle East Countries
8.4.4 Others
8.5 South America
8.5.1 Introduction
8.5.2 Argentina
8.5.3 Brazil
8.5.4 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 Business Overview
10.1.2 Product portfolio
10.1.3 Key Strategy
10.1.4 Recent Developments
10.2 Novartis
10.3 Biotechne
10.4 Roche
10.5 Abbvie
10.6 Pfizer
10.7 Johnson & Johnson
10.8 Sanofi
10.9 GE Healthcare
10.10 Bayer Healthcare Pharmaceuticals
10.11 A.G. Scientific, Inc.
10.12 Thermo Fisher Scientific
10.13 Abbott Diagnostics
10.14 Biocon
10.15 BD Biosciences
Chapter 11 Market Estimates and Forecast
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Therapeutic Application 2018-2024 (USD Million)
11.1.2 Market Estimates and Forecast by Cytokine Type 2018-2024 (USD Million)
11.1.3 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
